Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cyntegra is a cybersecurity and cyber resilience company that provides a patented Recovery Operating System (CyntOS) designed to mitigate the impact of ransomware and disruptive malware attacks. The company's technology enables organizations to restore compromised systems to a functional, pre-attack state in minutes, significantly reducing recovery time and associated costs. By utilizing a secure vault architecture with firmware-level controls, Cyntegra allows end-users—including non-technical staff like healthcare workers—to trigger system restoration without direct IT intervention. The company is particularly focused on protecting critical infrastructure, including finance, energy, and healthcare sectors, from catastrophic cyber disruption.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cyntegra.